Sam – Page 489 – biolegacy

It's Official: BiOptix Names New CEO

Post author:Sam
Post published:April 10, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Immunex Files Patent Infringement Complaint Against Sanofi, Regeneron

Post author:Sam
Post published:April 10, 2017
Post category:Drug Industry Daily

In a complaint filed in the District Court of the Central District of California, Immunex asserts Sanofi and Regeneron infringed on the Immunex patent for Dupixent, which the FDA approved…

Federal Judge Orders Propranolol Generic Price-Fixing Lawsuit to Proceed

Post author:Sam
Post published:April 10, 2017
Post category:Drug Industry Daily

A federal judge has ruled that a class-action antitrust lawsuit against several generics manufacturers, alleging price-fixing of propranolol capsules and tablets, can proceed in court. Source: Drug Industry Daily

GSK Seeks Supreme Court Ruling on Paxil Suit Jurisdiction

Post author:Sam
Post published:April 10, 2017
Post category:Drug Industry Daily

GlaxoSmithKline has asked the U.S. Supreme Court to rule on the proper jurisdiction for a suit over birth defects and its antidepressant Paxil. Source: Drug Industry Daily

Maryland Legislature Sends Generic Drug Price Gouging Bill to Governor

Post author:Sam
Post published:April 10, 2017
Post category:Drug Industry Daily

The Maryland state legislature has approved a bill to ban excessive price increases for generics and off-patent drugs, and is sending it to the state’s governor for final approval. Source:…

XBiotech Announces Additions To Its Scientific Advisory Board

Post author:Sam
Post published:April 9, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

These 3 Big Biotechs Could Have New Blockbuster Drugs Very Soon

Post author:Sam
Post published:April 9, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"These 3 Big Biotechs Could Have New Blockbuster Drugs Very Soon" ALT"These 3 Big Biotechs Could Have New Blockbuster Drugs Very Soon"April 10, 2017By Alex Keown, BioSpace.com Breaking…

EnXray Raises ??2.3 Million To Fund Commercial Launch

Post author:Sam
Post published:April 9, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC, Bristol-Myers Squibb Drugs

Post author:Sam
Post published:April 9, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca, Bristol-Myers Squibb Drugs" ALT"Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca, Bristol-Myers Squibb Drugs"April…

Bioverativ Appoints Executive Vice President, Research And Development

Post author:Sam
Post published:April 9, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace